SIRT3 and head and neck squamous cell carcinoma: Consistent with mitochondrial Sirt3 inhibition, LC-0296 increased global mitochondrial protein acetylation, acetylation of the Sirt3 target glutamate dehydrogenase, and reactive oxygen species levels in head and neck squamous cell carcinoma (HNSCC) cell lines [160].